Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz Pharmaceuticals Appoints Jennifer Cook and Mark Smith, M.D. to its Board of Directors
07:30am, Tuesday, 17'th Nov 2020
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jennifer Cook and Mark D. Smith, M.D. have been appointed to the Company's Board of Directors, effect
Data at ASH 2020 Annual Meeting Highlights Jazz Pharmaceuticals' Commitment to Advancing Hematology/Oncology Research
07:30am, Thursday, 05'th Nov 2020
DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 11 company-sponsored abstracts, in addition to two abstracts from collaboration trials with The Univer
Jazz Pharmaceuticals plc's (JAZZ) CEO Bruce Cozadd on Q3 2020 Results - Earnings Call Transcript
10:34pm, Monday, 02'nd Nov 2020
Jazz Pharmaceuticals plc's (JAZZ) CEO Bruce Cozadd on Q3 2020 Results - Earnings Call Transcript
Jazz Pharmaceuticals: Q3 Earnings Insights
05:17pm, Monday, 02'nd Nov 2020
Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) moved higher by 7.9% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 5.12% year over year to $4
Jazz Pharmaceuticals's Earnings: A Preview
11:03am, Friday, 30'th Oct 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) releases its next round of earnings this Monday, November 02. Here is Benzinga's essential guide to Jazz Pharmaceuticals's Q3 earnings report.
BofA Securities Top 10 US Stock Ideas for the Rest of 2021
09:53am, Wednesday, 28'th Oct 2020
It is almost hard to believe, in what has been one of the most unbelievable years in recent history, that Halloween is this weekend and Thanksgiving is right around the corner.
Albireo's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
07:27am, Friday, 11'th Sep 2020
Albireo reports positive data from Phase 3 trial. Jazz Pharmaceuticals inks new cancer deal with Redx Pharma.
ImmunoGen: Turning Around In A Coronavirus Environment
02:03pm, Tuesday, 25'th Aug 2020
ImmunoGen is a turnaround stock that has tremendous potential. After temporary regulatory and clinical setbacks, the company is on a vigorous campaign for a change.
Jazz Pharma (JAZZ) Beats on Q2 Earnings & Sales, Raises View
04:10pm, Wednesday, 05'th Aug 2020
Jazz Pharmaceuticals (JAZZ) reports better-than-expected second-quarter 2020 earnings and revenues. It raises its guidance for 2020. Shares rise.
What's Behind Jazz Pharmaceuticals' Q2 Revenue and Earnings Beats
10:38am, Wednesday, 05'th Aug 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) hasn't given investors much good news so far in 2020. The drugmaker's first-quarter results announced in May were disappointing. Jazz stock has dropped 23% year to
Jazz Pharmaceuticals (JAZZ) Q2 Earnings and Revenues Beat Estimates
10:45pm, Tuesday, 04'th Aug 2020
Jazz (JAZZ) delivered earnings and revenue surprises of 9.76% and 11.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Jazz Pharmaceuticals Announces Second Quarter 2020 Financial Results
08:05pm, Tuesday, 04'th Aug 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2020 and updated its 2020 financial guidance.
Preview: Jazz Pharmaceuticals's Earnings
04:12pm, Monday, 03'rd Aug 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) announces its next round of earnings this Tuesday, August 04. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.Earnings
Harmony Biosciences Starts U.S. IPO Effort
12:23pm, Friday, 31'st Jul 2020
Harmony Biosciences has filed to raise $100 million in an IPO, although the final figure will likely differ.
10 Biggest Biotechnology Companies
11:32pm, Thursday, 30'th Jul 2020
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
